Logo image of FROG

JFROG LTD (FROG) Stock Fundamental Analysis

NASDAQ:FROG - IL0011684185 - Common Stock

47.04 USD
+0.15 (+0.32%)
Last: 8/22/2025, 8:10:30 PM
47.45 USD
+0.41 (+0.87%)
After Hours: 8/22/2025, 8:10:30 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FROG. FROG was compared to 282 industry peers in the Software industry. FROG has a great financial health rating, but its profitability evaluates not so good. FROG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
FROG had a positive operating cash flow in the past year.
FROG had negative earnings in each of the past 5 years.
Each year in the past 5 years FROG had a positive operating cash flow.
FROG Yearly Net Income VS EBIT VS OCF VS FCFFROG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With a Return On Assets value of -7.14%, FROG perfoms like the industry average, outperforming 40.64% of the companies in the same industry.
Looking at the Return On Equity, with a value of -10.44%, FROG is in line with its industry, outperforming 50.53% of the companies in the same industry.
Industry RankSector Rank
ROA -7.14%
ROE -10.44%
ROIC N/A
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
FROG Yearly ROA, ROE, ROICFROG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

Looking at the Gross Margin, with a value of 75.53%, FROG is in the better half of the industry, outperforming 69.26% of the companies in the same industry.
FROG's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for FROG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
FROG Yearly Profit, Operating, Gross MarginsFROG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
FROG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FROG has been increased compared to 5 years ago.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FROG Yearly Shares OutstandingFROG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FROG Yearly Total Debt VS Total AssetsFROG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

FROG has an Altman-Z score of 8.68. This indicates that FROG is financially healthy and has little risk of bankruptcy at the moment.
FROG has a better Altman-Z score (8.68) than 83.75% of its industry peers.
There is no outstanding debt for FROG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.68
ROIC/WACCN/A
WACC11.26%
FROG Yearly LT Debt VS Equity VS FCFFROG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

FROG has a Current Ratio of 2.13. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
FROG has a Current ratio of 2.13. This is in the better half of the industry: FROG outperforms 64.66% of its industry peers.
FROG has a Quick Ratio of 2.13. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FROG (2.13) is better than 65.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
FROG Yearly Current Assets VS Current LiabilitesFROG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.77% over the past year.
The Earnings Per Share has been growing by 178.78% on average over the past years. This is a very strong growth
Looking at the last year, FROG shows a very strong growth in Revenue. The Revenue has grown by 21.97%.
Measured over the past years, FROG shows a very strong growth in Revenue. The Revenue has been growing by 32.56% on average per year.
EPS 1Y (TTM)10.77%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)21.97%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%23.46%

3.2 Future

Based on estimates for the next years, FROG will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.80% on average per year.
FROG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.27% yearly.
EPS Next Y9.67%
EPS Next 2Y13.13%
EPS Next 3Y18.8%
EPS Next 5YN/A
Revenue Next Year19.38%
Revenue Next 2Y17.63%
Revenue Next 3Y16.87%
Revenue Next 5Y14.27%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FROG Yearly Revenue VS EstimatesFROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
FROG Yearly EPS VS EstimatesFROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 65.33, the valuation of FROG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of FROG is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.24, FROG is valued quite expensively.
Based on the Price/Forward Earnings ratio of 56.55, the valuation of FROG can be described as expensive.
FROG's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, FROG is valued quite expensively.
Industry RankSector Rank
PE 65.33
Fwd PE 56.55
FROG Price Earnings VS Forward Price EarningsFROG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

FROG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FROG is cheaper than 67.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.57
EV/EBITDA N/A
FROG Per share dataFROG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FROG's earnings are expected to grow with 18.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.76
PEG (5Y)N/A
EPS Next 2Y13.13%
EPS Next 3Y18.8%

0

5. Dividend

5.1 Amount

FROG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JFROG LTD

NASDAQ:FROG (8/22/2025, 8:10:30 PM)

After market: 47.45 +0.41 (+0.87%)

47.04

+0.15 (+0.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners77.46%
Inst Owner Change0.04%
Ins Owners13.41%
Ins Owner Change-3.79%
Market Cap5.49B
Analysts82.31
Price Target52.24 (11.05%)
Short Float %2.73%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.87%
Min EPS beat(2)8.08%
Max EPS beat(2)19.67%
EPS beat(4)4
Avg EPS beat(4)24.98%
Min EPS beat(4)8.08%
Max EPS beat(4)39.08%
EPS beat(8)8
Avg EPS beat(8)30.04%
EPS beat(12)12
Avg EPS beat(12)395.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.87%
Min Revenue beat(2)1.57%
Max Revenue beat(2)2.17%
Revenue beat(4)3
Avg Revenue beat(4)1.16%
Min Revenue beat(4)-0.34%
Max Revenue beat(4)2.17%
Revenue beat(8)4
Avg Revenue beat(8)0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.04%
Revenue beat(16)7
Avg Revenue beat(16)0.21%
PT rev (1m)13.86%
PT rev (3m)17.04%
EPS NQ rev (1m)2.74%
EPS NQ rev (3m)-2.6%
EPS NY rev (1m)0.82%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)2.04%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)1.21%
Valuation
Industry RankSector Rank
PE 65.33
Fwd PE 56.55
P/S 11.57
P/FCF 39.57
P/OCF 38.77
P/B 6.64
P/tB 13.54
EV/EBITDA N/A
EPS(TTM)0.72
EY1.53%
EPS(NY)0.83
Fwd EY1.77%
FCF(TTM)1.19
FCFY2.53%
OCF(TTM)1.21
OCFY2.58%
SpS4.07
BVpS7.08
TBVpS3.47
PEG (NY)6.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.14%
ROE -10.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.53%
FCFM 29.23%
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 10.49%
Cap/Sales 0.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z 8.68
F-Score4
WACC11.26%
ROIC/WACCN/A
Cap/Depr(3y)19.73%
Cap/Depr(5y)42.11%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.77%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y9.67%
EPS Next 2Y13.13%
EPS Next 3Y18.8%
EPS Next 5YN/A
Revenue 1Y (TTM)21.97%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%23.46%
Revenue Next Year19.38%
Revenue Next 2Y17.63%
Revenue Next 3Y16.87%
Revenue Next 5Y14.27%
EBIT growth 1Y-47.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year68.24%
EBIT Next 3Y39%
EBIT Next 5YN/A
FCF growth 1Y460.55%
FCF growth 3Y67.17%
FCF growth 5Y67.4%
OCF growth 1Y405.3%
OCF growth 3Y58.42%
OCF growth 5Y61.81%